Rethinking U.S. opioid policy

As a subject matter expert on U.S. policy for prescription opioid regulation and a patient advocate, I believe the 2022 CDC opioid guidelines contain fundamental errors that jeopardize patient care and advocate for their withdrawal or the removal of CDC from future pain medicine policy-making.

Related Keywords

,Centers For Disease ,Department Of Veterans Affairs ,Veterans Affairs ,Us Drug Enforcement Administration ,Us Congress ,Workgroup Committee ,Disease Control ,Scientific Counselors ,Opioid Workgroup ,